CORRESP Filing
GeoVax Labs, Inc.
Date: June 20, 2025 · CIK: 0000832489 · Accession: 0001437749-25-020817
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288085
Referenced dates: June 17, 2025
Letter
govx20250618_corresp.htm
GeoVax Labs, Inc.
1900 Lake Park Drive
Suite 380
Smyrna, Georgia 30080
(678) 384-7220
June 20, 2025
VIA EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
Re:
GeoVax Labs, Inc.
Registration Statement on Form S-1
File No. 333-288085
Ladies and Gentlemen:
By letter dated June 17, 2025, and in accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), GeoVax Labs, Inc., a Delaware corporation (the “Registrant”), requested that the effectiveness of the registration statement on Form S-1 (File No. 333-288085) filed with the U.S. Securities and Exchange Commission on June 16, 2025, be accelerated so that the registration statement becomes effective at 9:00 a.m. Eastern Time on Friday, June 20, 2025 or as soon thereafter as practicable.
We now hereby amend our request so that the registration statement instead becomes effective at 5:00 p.m. Eastern Time on Monday, June 23, 2025 or as soon thereafter as practicable. In this regard, the Registrant continues to be aware of its obligations under the Securities Act.
If you have any questions or comments, please contact me or if you prefer, you may contact our counsel, F. Reid Avett of Womble Bond Dickinson (US) LLP, by telephone at (202) 857-4425, or by email at reid.avett@wbd-us.com.
Very truly yours,
GeoVax Labs, Inc.
Show Raw Text
CORRESP 1 filename1.htm govx20250618_corresp.htm GeoVax Labs, Inc. 1900 Lake Park Drive Suite 380 Smyrna, Georgia 30080 (678) 384-7220 June 20, 2025 VIA EDGAR Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: GeoVax Labs, Inc. Registration Statement on Form S-1 File No. 333-288085 Ladies and Gentlemen: By letter dated June 17, 2025, and in accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), GeoVax Labs, Inc., a Delaware corporation (the “Registrant”), requested that the effectiveness of the registration statement on Form S-1 (File No. 333-288085) filed with the U.S. Securities and Exchange Commission on June 16, 2025, be accelerated so that the registration statement becomes effective at 9:00 a.m. Eastern Time on Friday, June 20, 2025 or as soon thereafter as practicable. We now hereby amend our request so that the registration statement instead becomes effective at 5:00 p.m. Eastern Time on Monday, June 23, 2025 or as soon thereafter as practicable. In this regard, the Registrant continues to be aware of its obligations under the Securities Act. If you have any questions or comments, please contact me or if you prefer, you may contact our counsel, F. Reid Avett of Womble Bond Dickinson (US) LLP, by telephone at (202) 857-4425, or by email at reid.avett@wbd-us.com. Very truly yours, GeoVax Labs, Inc. By: /s/ Mark W. Reynolds Mark W. Reynolds Chief Financial Officer